Literature DB >> 3091926

Non-ketotic hyperglycinaemia due to a deficiency of T-protein in the glycine cleavage system in liver and brain.

R B Schutgens, J L Ket, K Hayasaka, K Tada.   

Abstract

Non-ketotic hyperglycinaemia was diagnosed in a girl at 3 weeks of age because of the typical clinical presentation, the elevated glycine concentration in urine, plasma and especially in cerebrospinal fluid and the normal profile of organic acids in urine. An EEG showed the typical burst suppression pattern. Therapeutic approaches with either pyridoxine (50 mg d-1) alone or in combination with N5-formyltetrahydrofolate (3 X 3 mg d-1) or with strychnine (0.3 mg per kg body weight) did not result in improvement. In postmortem liver and brain of the patient the overall activity of the glycine cleavage system was deficient; examination of the activity of the individual components of the glycine cleavage system in the tissues revealed that the activity of the T-protein was undetectable, whereas that of the other components and of lipoamide dehydrogenase was normal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091926     DOI: 10.1007/bf01799462

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  12 in total

1.  Comparative study on major pathways of glycine and serine catabolism in vertebrate livers.

Authors:  T Yoshida; G Kikuchi
Journal:  J Biochem       Date:  1972-12       Impact factor: 3.387

2.  Reduction of the level of the glycine cleavage system in the rat liver resulting from administration of dipropylacetic acid: an experimental approach to hyperglycinemia.

Authors:  H Kochi; K Hayasaka; K Hiraga; G Kikuchi
Journal:  Arch Biochem Biophys       Date:  1979-12       Impact factor: 4.013

3.  Electroencephalographic findings in three patients with nonketotic hyperglycinemia.

Authors:  A M Seppäläinen; S Similä
Journal:  Epilepsia       Date:  1971-03       Impact factor: 5.864

4.  The mitochondrial glycine cleavage system. Functional association of glycine decarboxylase and aminomethyl carrier protein.

Authors:  K Hiraga; G Kikuchi
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

5.  Effects of the metabolites of the branched-chain amino acids and cysteamine on the glycine cleavage system.

Authors:  K Hayasaka; K Tada
Journal:  Biochem Int       Date:  1983-02

6.  Glycine metabolism by rat liver mitochondria. Reconstruction of the reversible glycine cleavage system with partially purified protein components.

Authors:  Y Motokawa; G Kikuchi
Journal:  Arch Biochem Biophys       Date:  1974-10       Impact factor: 4.013

7.  Purification and characterization of chicken liver T-protein, a component of the glycine cleavage system.

Authors:  K Okamura-Ikeda; K Fujiwara; Y Motokawa
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

8.  Defective glycine cleavage system in nonketotic hyperglycinemia. Occurrence of a less active glycine decarboxylase and an abnormal aminomethyl carrier protein.

Authors:  K Hiraga; H Kochi; K Hayasaka; G Kikuchi; W L Nyhan
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

9.  Glycine metabolism by rat liver mitochondria. IV. Isolation and characterization of hydrogen carrier protein, an essential factor for glycine metabolism.

Authors:  Y Motokawa; G Kikuchi
Journal:  Arch Biochem Biophys       Date:  1969-12       Impact factor: 4.013

10.  Dipropylacetate (valproate) and glycine metabolism.

Authors:  J Jaeken; L Corbeel; P Casaer; H Carchon; E Eggermont; R Eeckels
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

View more
  2 in total

Review 1.  The biochemical basis of mitochondrial diseases.

Authors:  H R Scholte
Journal:  J Bioenerg Biomembr       Date:  1988-04       Impact factor: 2.945

2.  Purification and partial characterization of the glycine decarboxylase multienzyme complex from Eubacterium acidaminophilum.

Authors:  W Freudenberg; J R Andreesen
Journal:  J Bacteriol       Date:  1989-04       Impact factor: 3.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.